Acadia Healthcare (ACHC) Tops Q4 EPS by 2c, Offers Q1 and FY Guidance

Acadia Healthcare (NASDAQ: ACHC) reported Q4 EPS of $0.51, $0.02 better than the analyst estimate of $0.49. Revenue for the quarter came in at $780.2 million versus the consensus estimate of $780.27 million.

GUIDANCE:

Acadia Healthcare sees Q1 2020 EPS of $0.37-$0.42, versus the consensus of $0.46. Acadia Healthcare sees Q1 2020 revenue of $795-805 million, versus the consensus of $797.3 million.

Acadia Healthcare sees FY2020 EPS of $2.20-$2.40, versus the consensus of $2.33. Acadia Healthcare sees FY2020 revenue of $3.28-3.34 billion, versus the consensus of $3.27 billion.

For earnings history and earnings-related data on Acadia Healthcare (ACHC) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Pfizer lung cancer drug misses survival goal in Phase 3 trial
• Sun Communities names Ileana McAlary as general counsel and EVP